New findings from ALLHAT do not support a preference for calcium blockers, alpha blockers, or ACE inhibitors over thiazide diuretics in patients with the metabolic syndrome, despite their more favorable metabolic profiles. Heartwire
Authors say the patients represent a cross-section of the Danish population undergoing percutaneous coronary intervention and suggest these stents are safe. Medscape Medical News
Sorafenib, a new antineoplastic drug used to treat patients with advanced renal cell and hepatocellular cancer, significantly increased the risk of developing hypertension. Medscape Medical News
New research confirms that stress at work can increase the risk for coronary heart disease and shows for the first time that such stress mediates its effects through biological pathways. Medscape Medical News
The factor-X inhibitor was no worse than vitamin K antagonists in preventing stroke and thromboembolism but caused significantly more bleeding. Medscape Medical News
Measures of exercise performance seem to improve when hawthorn extract is given along with standard therapy, a Cochrane review concludes. Medscape Medical News
Accumulating evidence points to a significant association between low testosterone and mortality. Medscape spoke to Dr. Adrian Dobs about the results of recent studies in this area. Medscape Urology
New findings from a heart trial do not support a preference for calcium blockers, alpha-blockers, or angiotensin-converting enzyme inhibitors vs thiazide diuretics in patients with metabolic syndrome. Medscape Medical News
Studies show that oral contraceptives may protect against ovarian cancer, a Western diet may increase risk for metabolic syndrome, insurance copayments may deter women from getting mammograms, cold medicines can be dangerous to young children, 2 stents for treating myocardial infarction may be equivalent, and gastric banding may lead to remission of type 2 diabetes. Medscape Medical News
